What is Rael?
Rael offers a comprehensive range of holistic health products meticulously designed for menstrual and cycle care. Their product line includes essential items such as pads and tampons, alongside advanced supplements and skincare solutions, all formulated with clean, effective ingredients. The company's core mission is to support women throughout their entire cycle, emphasizing sustainability and sensitivity in its offerings. Rael caters to a diverse clientele, including individuals managing irregular cycles or conditions like Polycystic Ovary Syndrome (PCOS). Founded by Yanghee Paik, Rael uniquely blends Korean beauty innovation with a holistic approach to personal care, positioning itself as a leader in the women's wellness market.
How much funding has Rael raised?
Rael has raised a total of $52.9M across 3 funding rounds:
Series A
$17.5M
Debt
$350K
Series B
$35M
Series A (2018): $17.5M with participation from SoftBank Ventures Asia, Mirae Asset Venture Investment, and Pritzker Group Venture Capital
Debt (2020): $350K led by PPP
Series B (2022): $35M supported by Colopl Next, ST Capital, Aarden Partners, and Signite Partners
Key Investors in Rael
Colopl Next
COLOPL NEXT, Inc. is a venture capital firm established in 2015 that invests in a wide range of startups across various industries, focusing on companies in Japan, the U.S., and South Korea. The firm primarily targets BtoC entertainment sectors and supports young entrepreneurs who are expected to lead the next generation.
Signite Partners
SIGNITE is a venture capital firm under the Shinsegae Group, focusing on discovering and investing in startups that innovate lifestyle through technology in the beauty, fashion, and retail sectors. The company aims to ignite a startup ecosystem that enhances everyday life.
SoftBank Ventures Asia
Founded in 2000, SoftBank Ventures Asia is the early-stage venture capital arm of the SoftBank Group. Its expertise lies in ICT investments including AI, IoT, and smart robotics. SoftBank Ventures Asia looks for early to growth-stage start-ups that have strong business potential in the global market.
What's next for Rael?
The recent major strategic investment signifies a pivotal growth phase for Rael, likely enabling the company to expand its product development, enhance its sustainable sourcing initiatives, and broaden its market reach. This infusion of capital, contextualized by the 'major enterprise-level funding' descriptor, suggests Rael is poised for significant scaling. Future endeavors may include further innovation in clean ingredient technology, strengthening its direct-to-consumer channels, and potentially exploring international market expansion. The company's commitment to holistic well-being and sustainable practices positions it favorably for continued success in the evolving health and beauty sector.
See full Rael company page
